Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Shang Lin

AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jeong SR, Lin SG, Hamilton P, Sott A, Yousaf S. Experience of Using Telehealth for Foot and Ankle Examination During The SARS-COV-2 Crisis. Foot Ankle Spec. 2021 Oct; 14(5):453-457. PMID: 34142590.
      View in: PubMed
    2. Leung MST, Lin SG, Uthayanan L, Harky A. Effects of antidiabetic medications on cardiovascular outcomes. J Card Surg. 2020 Oct; 35(10):2759-2767. PMID: 32939829.
      View in: PubMed
    3. Leung MST, Lin SG, Chow J, Harky A. COVID-19 and Oncology: Service transformation during pandemic. Cancer Med. 2020 10; 9(19):7161-7171. PMID: 32810386.
      View in: PubMed
    4. Konda VJ, Hart J, Lin S, Tretiakova M, Gordon IO, Campbell L, Kulkarni A, Bissonnette M, Seewald S, Waxman I. Evaluation of microvascular density in Barrett's associated neoplasia. Mod Pathol. 2013 Jan; 26(1):125-30. PMID: 22918163.
      View in: PubMed
    5. Shah MY, Vasanthakumar A, Barnes NY, Figueroa ME, Kamp A, Hendrick C, Ostler KR, Davis EM, Lin S, Anastasi J, Le Beau MM, Moskowitz IP, Melnick A, Pytel P, Godley LA. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res. 2010 Jul 15; 70(14):5840-50. PMID: 20587527.
      View in: PubMed
    6. Godley LA, Njiaju UO, Green M, Weiner H, Lin S, Odenike O, Rich ES, Artz A, Van Besien K, Daugherty CK, Zhang Y, Le Beau MM, Stock W, Larson RA. Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant. Leuk Lymphoma. 2010 Jun; 51(6):995-1006. PMID: 20536346.
      View in: PubMed
    7. van Besien K, Dew A, Lin S, Joseph L, Godley LA, Larson RA, Odenike T, Rich E, Stock W, Wickrema A, Artz AS. Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. Leuk Lymphoma. 2009 Nov; 50(11):1809-17. PMID: 19821799.
      View in: PubMed
    8. Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92. PMID: 19690526.
      View in: PubMed
    9. Chennat J, Ross AS, Konda VJ, Lin S, Noffsinger A, Hart J, Waxman I. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Gastrointest Endosc. 2009 Sep; 70(3):417-21. PMID: 19555948.
      View in: PubMed
    10. Choong NW, Mauer AM, Haraf DJ, Lester E, Hoffman PC, Kozloff M, Lin S, Dancey JE, Szeto L, Grushko T, Olopade OI, Salgia R, Vokes EE. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11. PMID: 18758303.
      View in: PubMed
    11. Gofrit ON, Stadler WM, Zorn KC, Lin S, Silvestre J, Shalhav AL, Zagaja GP, Steinberg GD. Adjuvant chemotherapy in lymph node positive bladder cancer. Urol Oncol. 2009 Mar-Apr; 27(2):160-4. PMID: 18440835.
      View in: PubMed
    12. Alexander GC, Lin S, Sayla MA, Wynia MK. Development of a measure of physician engagement in addressing racial and ethnic health care disparities. Health Serv Res. 2008 Apr; 43(2):773-84. PMID: 18370978.
      View in: PubMed
    13. Mendiola FP, Zorn KC, Mikhail AA, Lin S, Orvieto MA, Zagaja GP, Shalhav AL. Urinary and sexual function outcomes among different age groups after robot-assisted laparoscopic prostatectomy. J Endourol. 2008 Mar; 22(3):519-24. PMID: 18355146.
      View in: PubMed
    14. Konda VJ, Ross AS, Ferguson MK, Hart JA, Lin S, Naylor K, Noffsinger A, Posner MC, Dye C, Cislo B, Stearns L, Waxman I. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008 Feb; 6(2):159-64. PMID: 18096439.
      View in: PubMed
    15. Mikhail AA, Song DH, Zorn KC, Orvieto MA, Taxy JB, Lin SP, Mendiola FP, Shalhav AL, Zagaja GP. Sural nerve grafting in robotic laparoscopic radical prostatectomy: interim report. J Endourol. 2007 Dec; 21(12):1547-51. PMID: 18044998.
      View in: PubMed
    16. Msezane LP, Gofrit ON, Lin S, Shalhav AL, Zagaja GP, Zorn KC. Prostate weight: an independent predictor for positive surgical margins during robotic-assisted laparoscopic radical prostatectomy. Can J Urol. 2007 Oct; 14(5):3697-701. PMID: 17949525.
      View in: PubMed
    17. Gofrit ON, Zorn KC, Taxy JB, Lin S, Zagaja GP, Steinberg GD, Shalhav AL. Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer. J Urol. 2007 Nov; 178(5):1925-8. PMID: 17868725.
      View in: PubMed
    18. Zorn KC, Orvieto MA, Mikhail AA, Gofrit ON, Lin S, Schaeffer AJ, Shalhav AL, Zagaja GP. Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology. 2007 Feb; 69(2):300-5. PMID: 17320668.
      View in: PubMed
    19. Zorn KC, Mendiola FP, Rapp DE, Mikhail AA, Lin S, Orvieto MA, Zagaja GP, Shalhav AL. Age-stratified outcomes after robotic-assisted laparoscopic radical prostatectomy. J Robot Surg. 2007; 1(2):125-32. PMID: 25484948.
      View in: PubMed
    20. King A, Munisamy G, de Wit H, Lin S. Attenuated cortisol response to alcohol in heavy social drinkers. Int J Psychophysiol. 2006 Mar; 59(3):203-9. PMID: 16359745.
      View in: PubMed
    21. Gajewski TF, Sosman J, Gerson SL, Liu L, Dolan E, Lin S, Vokes EE. Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma. Clin Cancer Res. 2005 Nov 01; 11(21):7861-5. PMID: 16278409.
      View in: PubMed
    22. Hansen RJ, Nagasubramanian R, Delaney SM, Cherian MM, Lin S, Kogan SC, Dolan ME. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities. J Pharmacol Exp Ther. 2005 Dec; 315(3):1247-55. PMID: 16126841.
      View in: PubMed
    Lin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (163) concept(s)
    _
    Co-Authors Expand Description
    See all (31) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Physical Neighbors Expand Description
    _